The STTAR-US Study: A Pivotal Study of Transcatheter Tricuspid Annular Repair in the US

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 600 participants.

Also called NCT06700239

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 600 participants (planned count) (from the registry)
Sponsor
Micro Interventional Devices (from the registry)
Registry
  • NCT NCT06700239
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06700239. Randomized; single masking; primary purpose treatment. Start 2025-12-31 (anticipated); primary completion 2027-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The STTAR-US Study: A Pivotal Study of Transcatheter Tricuspid Annular Repair in the US
Acronym
STTAR-US
Condition
Tricuspid Regurgitation Functional
Condition
Tricuspid Regurgitation
Condition
Severe Tricuspid Valve Regurgitation
Intervention (Device)
MIA_T Device
Lead sponsor
Micro Interventional Devices (class: industry)

Record details

Record id
cardio:ct-nct06700239
Content hash
d69db4cfc426a6b4da0e2db790f2e78ceff7953ed9c519c30c2d6f338ab369e9